[
  {
    "ts": null,
    "headline": "TMO Receives FDA Approval for Oncomine Dx Target Test",
    "summary": "Thermo Fisher secures FDA approval for its Oncomine Dx Target Test to identify NSCLC patients eligible for HERNEXEOS treatment.",
    "url": "https://finnhub.io/api/news?id=56cf844728f614b3b459cd52e312022e837e30d7f7149ee595f0ad4f65ed8b89",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755263700,
      "headline": "TMO Receives FDA Approval for Oncomine Dx Target Test",
      "id": 136408554,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher secures FDA approval for its Oncomine Dx Target Test to identify NSCLC patients eligible for HERNEXEOS treatment.",
      "url": "https://finnhub.io/api/news?id=56cf844728f614b3b459cd52e312022e837e30d7f7149ee595f0ad4f65ed8b89"
    }
  },
  {
    "ts": null,
    "headline": "Bruker: Former Academia Customer Strength, Now Incredible Weakness",
    "summary": "Bruker faces challenges amid NIH funding cuts and academic reliance. Short-term risks are high, but investors may benefit from a recovery. See more on BRKR.",
    "url": "https://finnhub.io/api/news?id=3e4501f5a4c79ca37b1acc02d0272144724791c3eb8cd6af84b9a2be3548d946",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755228696,
      "headline": "Bruker: Former Academia Customer Strength, Now Incredible Weakness",
      "id": 136366509,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2215160149/image_2215160149.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "Bruker faces challenges amid NIH funding cuts and academic reliance. Short-term risks are high, but investors may benefit from a recovery. See more on BRKR.",
      "url": "https://finnhub.io/api/news?id=3e4501f5a4c79ca37b1acc02d0272144724791c3eb8cd6af84b9a2be3548d946"
    }
  }
]